{"entity":{"type":"insider","cik":"0001741382","url":"/insider/0001741382","json_url":"/insider/0001741382.json","name":"Beetham Thomas W.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":7,"first":"2020-02-19","last":"2024-09-30","span_basis":"filed_date"},"name_variants":[{"name":"Beetham Thomas W.","source":"filing","n_filings":7,"first_seen":"2020-02-19","last_seen":"2024-09-30"}],"transactions":[{"id":2206412,"accession":"0000950170-24-110485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-110485","line_url":"/filing/0000950170-24-110485#line-1","is_derivative":false,"issuer_cik":"0001590750","issuer_name":"Viridian Therapeutics, Inc.\\DE","issuer_ticker":"VRDN","issuer_name_source":null,"issuer_url":"/issuer/0001590750","owner_cik":"0001741382","owner_name":"Beetham Thomas W.","owner_display_name":"Beetham Thomas W.","owner_url":"/insider/0001741382","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":23.41,"price_display":"23.41","price_state":"stated","total_value":117050.0,"total_display":"117,050.00","total_whole":"117,050","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-09-30","scope":"insider"},{"id":4709429,"accession":"0000899243-21-036598","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-036598","line_url":"/filing/0000899243-21-036598#line-1","is_derivative":false,"issuer_cik":"0001690585","issuer_name":"Magenta Therapeutics, Inc.","issuer_ticker":"MGTA","issuer_name_source":null,"issuer_url":"/issuer/0001690585","owner_cik":"0001741382","owner_name":"Beetham Thomas W.","owner_display_name":"Beetham Thomas W.","owner_url":"/insider/0001741382","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6103.0,"shares_display":"6,103","price_per_share":6.73,"price_display":"6.73","price_state":"stated","total_value":41073.19,"total_display":"41,073.19","total_whole":"41,073","shares_owned_after":13897.0,"shares_owned_after_display":"13,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-16","filed_date":"2021-09-20","scope":"insider"},{"id":5111946,"accession":"0001179110-21-001370","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-001370","line_url":"/filing/0001179110-21-001370#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741382","owner_name":"Beetham Thomas W.","owner_display_name":"Beetham Thomas W.","owner_url":"/insider/0001741382","role":"Officer (EVP & Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Legal Officer","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2477.0,"shares_display":"2,477","price_per_share":22.09,"price_display":"22.09","price_state":"stated","total_value":54716.93,"total_display":"54,716.93","total_whole":"54,717","shares_owned_after":297523.0,"shares_owned_after_display":"297,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-05","scope":"insider"},{"id":3043344,"accession":"0001104659-20-080552","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-080552","line_url":"/filing/0001104659-20-080552","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741382","owner_name":"Beetham Thomas W.","owner_display_name":"Beetham Thomas W.","owner_url":"/insider/0001741382","role":"Officer (EVP & Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Legal Officer","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29589.0,"shares_display":"29,589","price_per_share":25.370174051167663,"price_display":"25.37","price_state":"stated","total_value":750678.08,"total_display":"750,678.08","total_whole":"750,678","shares_owned_after":2855.0,"shares_owned_after_display":"2,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider","n_lines":2},{"id":2623354,"accession":"0001179110-20-007295","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-007295","line_url":"/filing/0001179110-20-007295#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741382","owner_name":"Beetham Thomas W.","owner_display_name":"Beetham Thomas W.","owner_url":"/insider/0001741382","role":"Officer (EVP & Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Legal Officer","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13752.0,"shares_display":"13,752","price_per_share":25.07,"price_display":"25.07","price_state":"stated","total_value":344762.64,"total_display":"344,762.64","total_whole":"344,763","shares_owned_after":29589.0,"shares_owned_after_display":"29,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-10","filed_date":"2020-06-12","scope":"insider"},{"id":3251654,"accession":"0001179110-20-005046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-005046","line_url":"/filing/0001179110-20-005046","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741382","owner_name":"Beetham Thomas W.","owner_display_name":"Beetham Thomas W.","owner_url":"/insider/0001741382","role":"Officer (EVP & Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Legal Officer","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2518.0,"shares_display":"2,518","price_per_share":19.893756949960284,"price_display":"19.89","price_state":"stated","total_value":50092.48,"total_display":"50,092.48","total_whole":"50,092","shares_owned_after":30544.0,"shares_owned_after_display":"30,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-21","filed_date":"2020-04-22","scope":"insider","n_lines":2},{"id":3251646,"accession":"0001179110-20-005046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-005046","line_url":"/filing/0001179110-20-005046#line-1","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741382","owner_name":"Beetham Thomas W.","owner_display_name":"Beetham Thomas W.","owner_url":"/insider/0001741382","role":"Officer (EVP & Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Legal Officer","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47423.0,"shares_display":"47,423","price_per_share":19.06,"price_display":"19.06","price_state":"stated","total_value":903882.38,"total_display":"903,882.38","total_whole":"903,882","shares_owned_after":32107.0,"shares_owned_after_display":"32,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-20","filed_date":"2020-04-22","scope":"insider"},{"id":2354649,"accession":"0001179110-20-001872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-001872","line_url":"/filing/0001179110-20-001872#line-1","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741382","owner_name":"Beetham Thomas W.","owner_display_name":"Beetham Thomas W.","owner_url":"/insider/0001741382","role":"Officer (EVP & Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Legal Officer","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59.0,"shares_display":"59","price_per_share":18.58,"price_display":"18.58","price_state":"stated","total_value":1096.22,"total_display":"1,096.22","total_whole":"1,096","shares_owned_after":79530.0,"shares_owned_after_display":"79,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-14","filed_date":"2020-02-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001590750","name":"Viridian Therapeutics, Inc.\\DE","url":"/issuer/0001590750","role":"Officer (Chief Operating Officer)","n_filings":1,"first_seen":"2024-09-30","last_seen":"2024-09-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001690585","name":"Magenta Therapeutics, Inc.","url":"/issuer/0001690585","role":"Officer","n_filings":1,"first_seen":"2021-09-20","last_seen":"2021-09-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001730430","name":"Kiniksa Pharmaceuticals, Ltd.","url":"/issuer/0001730430","role":"Officer (EVP & Chief Legal Officer)","n_filings":5,"first_seen":"2020-02-19","last_seen":"2021-02-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001741382","retrieved_at":"2026-08-23T05:34:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}